AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AngioDynamicsIntersect ENTAnika TherapeuticsMiMedx GroupAntares Pharma
SymbolNASDAQ:ANGONASDAQ:XENTNASDAQ:ANIKOTCMKTS:MDXGNASDAQ:ATRS
Price Information
Current Price$10.09$11.50$34.84$3.60$2.86
52 Week RangeBuyHoldBuyN/AStrong Buy
Beat the Market™ Rank
Overall Score2.02.31.90.61.9
Analysis Score3.34.03.30.03.8
Community Score2.22.92.52.92.8
Dividend Score0.00.00.00.00.0
Ownership Score1.04.01.00.01.0
Earnings & Valuation Score3.80.62.50.01.9
Analyst Ratings
Consensus RecommendationBuyHoldBuyN/AStrong Buy
Consensus Price Target$17.50$19.38$53.75N/A$5.25
% Upside from Price Target73.44% upside68.48% upside54.28% upsideN/A83.57% upside
Trade Information
Market Cap$384.16 million$363.04 million$476.06 million$397.94 million$476.81 million
Beta0.691.121.171.11.37
Average Volume307,269839,213195,023258,4501,556,243
Sales & Book Value
Annual Revenue$359.48 million$109.14 million$114.51 million$359.11 million$123.86 million
Price / Sales1.063.434.321.113.82
Cashflow$1.53 per shareN/A$2.61 per share$0.16 per shareN/A
Price / Cash6.61N/A13.3622.87N/A
Book Value$16.52 per share$3.75 per share$20.21 per share$0.45 per share$0.33 per share
Price / Book0.613.071.728.008.67
Profitability
Net Income$61.34 million$-42,990,000.00$27.19 million$-29,980,000.00$-2,030,000.00
EPS$0.83($1.37)$2.05N/A($0.01)
Trailing P/E Ratio7.82N/A19.040.00143.07
Forward P/E Ratio63.06N/A27.0111.92
P/E GrowthN/AN/A$6.21N/AN/A
Net Margins16.27%-48.61%20.87%N/A0.86%
Return on Equity (ROE)2.49%-43.72%11.27%N/A2.38%
Return on Assets (ROA)2.05%-36.28%9.40%N/A0.92%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%0.10%0.07%N/A0.85%
Current Ratio2.65%6.63%6.15%N/A3.01%
Quick Ratio1.52%5.67%4.81%N/A2.55%
Ownership Information
Institutional Ownership Percentage97.96%87.70%91.04%3.70%40.27%
Insider Ownership Percentage2.80%6.50%3.67%12.40%5.49%
Miscellaneous
Employees1,050393133N/A165
Shares Outstanding37.63 million32.56 million14.20 million110.55 million165.56 million
Next Earnings Date7/8/2020 (Estimated)8/6/2020 (Estimated)7/22/2020 (Estimated)6/16/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.